Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -3231.36x is 17299% below its 5-year average of -18.57x, near the low end of its 5-year range (-3231.36x–-1.06x).
As of the fiscal period ended Tuesday, December 31, 2024.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2024 (2024-12-31): -3231.36x.
INTEREST COVERAGE RATIO
-3231.36x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
-432.14x
INTEREST COVERAGE RATIO AVG 5Y
-18.57x
INTEREST COVERAGE RATIO AVG 10Y
-11.20x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-647.75%
CURRENT VS 5Y AVG
-17299.46%
CURRENT VS 10Y AVG
-28741.62%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.42x
median of 428 covered companies
CURRENT VS SECTOR MEDIAN
-59519.14%
vs the sector median at left
EyePoint Pharmaceuticals, Inc.
Market Cap
$271.73M
Interest Coverage Ratio
-3231.36x
TTM Avg
N/A
3Y Avg
-432.14x
5Y Avg
-18.57x
Market Cap
$267.48M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$266.33M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$265.45M
Interest Coverage Ratio
-530.37x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$263.41M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$281.22M
Interest Coverage Ratio
-25.79x
TTM Avg
0.59x
3Y Avg
0.59x
5Y Avg
0.59x
Market Cap
$262.97M
Interest Coverage Ratio
-1805.60x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$281.49M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$261.05M
Interest Coverage Ratio
-360.54x
TTM Avg
23.12x
3Y Avg
23.12x
5Y Avg
1139.56x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| EyePoint Pharmaceuticals, Inc. (EYPT) | $271.73M | -3231.36x | N/A | -432.14x | -18.57x |
| OraSure Technologies, Inc. (OSUR)vs › | $267.48M | N/A | N/A | N/A | N/A |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $266.33M | N/A | N/A | N/A | N/A |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $265.45M | -530.37x | N/A | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $263.41M | N/A | N/A | N/A | N/A |
| Aurora Cannabis Inc. (ACB)vs › | $281.22M | -25.79x | 0.59x | 0.59x | 0.59x |
| Palisade Bio, Inc. (PALI)vs › | $262.97M | -1805.60x | N/A | N/A | N/A |
| Fate Therapeutics, Inc. (FATE)vs › | $281.49M | N/A | N/A | N/A | N/A |
| AC Immune S.A. (ACIU)vs › | $261.05M | -360.54x | 23.12x | 23.12x | 1139.56x |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $283.85M | N/A | N/A | N/A | N/A |
Interest Coverage
-3231.4x
Debt/Equity
0.13
Current Ratio
4.50
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2024-12-31 | -3231.36x |
| 2023-06-30 | -52.32x |
| 2023-03-31 | -26.54x |
| 2022-12-31 | -56.00x |
| 2022-09-30 | -27.79x |
| 2022-06-30 | -34.81x |
| 2022-03-31 | -15.31x |
| 2021-12-31 | -13.00x |
| 2021-09-30 | -11.03x |
| 2021-06-30 | -7.98x |
| 2021-03-31 | -8.12x |
| 2020-12-31 | -6.97x |
| 2020-09-30 | -1.06x |
| 2020-06-30 | -6.17x |
| 2020-03-31 | -6.41x |
| 2019-12-31 | -5.03x |
| 2019-09-30 | -7.94x |
| 2019-06-30 | -6.36x |
| 2019-03-31 | -14.36x |
| 2018-12-31 | 16.26x |
| 2018-09-30 | -16.63x |
| 2018-06-30 | -13.59x |
| 2014-06-30 | -4012.00x |
| 2012-12-31 | -2648.00x |
| 2012-09-30 | -2590.00x |
